Researchers suggested that policymakers encourage reinvestment of capital into patient care and limit share buybacks based on the findings.

Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new ...

Cantor Fitzgerald reaffirmed its Neutral stance on Humana (NYSE:HUM) stock, maintaining the price target at $290.00. The stock, currently trading at $257.34, has experienced a significant 11.4% ...

Discover the latest DJIA trends and top-performing stocks, including Apple, Nvidia, and Berkshire Hathaway. Stay ahead in the ...

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain ...

UBS analyst Timothy Piper maintained a Buy rating on G.U.D. Holdings (GUDHF – Research Report) today and set a price target of A$13.00. The ...

Shares of United Airlines Holdings Inc. UAL slid 2.61% to $103.31 Tuesday, on what proved to be an all-around favorable ...

CVS has replaced its CEO, and is working to reassure investors. The stock has jumped more than 20% in the first weeks of 2025 ...

We recently compiled a list of the 11 Best Stocks To Invest In For Grandchildren. In this article, we are going to take a ...